Disease Severity Modifier in the NICE Single Technology Appraisal of Trastuzumab Deruxtecan: External Assessment Group Perspective Diarmuid CoughlanOluwatomi ArisaStephen Rice Commentary 05 October 2023 Pages: 5 - 9
The Difference Method Approach for Sampling Order Constrained Parameters: An Improved Implementation and Important Limitations Daniel Hill-McManus Practical Application 21 August 2023 Pages: 11 - 18
A Systematic Review of Methodologies Used in Models of the Treatment of Diabetes Mellitus Marina AntoniouCéu MateusAndrew Titman Systematic Review 22 September 2023 Pages: 19 - 40
Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis Melissa LannonTaylor DudaSunjay Sharma Systematic Review 26 September 2023 Pages: 41 - 68
Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada Aneeka HafeezLauren E. CiprianoSisira Sarma Original Research Article 19 August 2023 Pages: 69 - 90
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis Jedidiah I. MortonClara MarquinaZanfina Ademi Original Research Article Open access 22 August 2023 Pages: 91 - 107
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer Anthony J. HatswellMohammad A. ChaudharyRachael Lawrance Original Research Article Open access 14 September 2023 Pages: 109 - 116
Launch and Post-Launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition Daniel Tobias MichaeliThomas Michaeli Original Research Article Open access 19 October 2023 Pages: 117 - 131